Pharmafile Logo

Live Webinar: Poker face revealed: Using facial analysis to reveal deeper emotional insights

Thursday 28th February 2019, 10:00 EST / 15:00 GMT / 16:00 CET

Thursday 28th February 2019
10:00 EST / 15:00 GMT / 16:00 CET
Register now to secure your place » 

Does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions. Brief, involuntary flashes of emotion or ‘micro-expressions’ can reveal a lot about a person’s true feelings. As market researchers interested in the emotional responses driving people’s attitudes and behaviours, this information is invaluable but can often be difficult to obtain. One of the latest innovations in market research is facial analysis, which uses recognition software to detect a range of emotions in faces.

Register now to secure your place » 

Join us for this complimentary webinar event hosted in partnership with emotion measurement company, Affectiva, which has analysed over 5,000,000 faces and 24,000 adverts to understand how people respond to digital stimulus such as advertisements, websites and smartphone apps. We will demonstrate how, over the past several years, we’ve been using facial analysis in both qualitative and quantitative settings to delve further into respondents’ reactions to healthcare communications.

What are the key takeaways?

The theory
Learn more about the science and technology underpinning facial and emotional analysis.

Applications in healthcare MRX
Discover how we used facial analysis to deliver additional insights in a pharmaceutical setting.

Key considerations
Find out about the logistical challenges of using this methodology and how to overcome them.

Looking forwards
Explore future applications of facial analysis including integration with other technologies.

Gain answers to your key questions
At the end of the webinar there will be a live Q&A session. Start the conversation by submitting your questions in advance when you register.

Thursday 28th February 2019
10:00 EST / 15:00 GMT / 16:00 CET
Register now to secure your place »

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Pegasus’s Approach to Measurement Wins 3 Gold’s at 2014 AMEC International Summit in Amsterdam

Pegasus, the UK’s leading independent health communications consultancy, added three awards to its 2014 portfolio at last weekend’s AMEC International Summit 2014 in Amsterdam

Pegasus Crowned Health Consultancy of the Year at 2014 Sabre Emea Awards

Brighton consultancy adds top honour to its award wins

Pegasus shortlisted for ‘Consultancy of the year’ at 2014 Communique Awards

Brighton-based independent healthcare specialist looks to add award to growing list of accolades

Pegasus Moves to Brighton

Top UK Healthcare Communications Consultancy Moves to Brighton

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

Removing the Roadblocks to Effective Patient Treatment

How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...

The Difficulties of Living with Depression Don’t End with the Illness Itself

This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.

Patient Power: Too Much of a Good Thing?

Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding